It sounds like science fiction: Cough into your cell phone to get tested for COVID-19 instead of going in for a nasal-swab PCR test. But artificial intelligence / machine learning (AI / ML) researchers have been laying the groundwork for this for some time. Now Denver-based RAIsonance, Inc. is making it a reality.
On this episode of Future Perfect Tech, we're talking to Kitty Kolding, co-founder and CEO of RAIsonance, Inc., to learn more about her companies and their revolutionary medical and biometric products.
Can AI-diagnostic tools help us get back to "normal"? How do you train these models? How can you tell a COVID cough from asthma or a sore throat? Can asymptomatic carriers of COVID-19 really be identified with a cough? How do you avoid AI bias?
Kitty answers these questions and more.
Kitty is a successful start-up CEO, having led multiple early stage and mid stage start-ups across categories including marketing tech, marketing services, data and AI. She has founded and led three of her own companies, and has been hired into several start-ups by Founders and VC investors as a professional CEO, to drive more disciplined and productive business operations.
Raisonance is the parent company of family of AI-powered biometric safety and health screening companies focused on impacting respiratory illnesses.
Kitty has been quoted across major media outlets, such as The New York Times, The Wall Street Journal, USA Today, and has been a featured speaker at leading industry conferences.
Learn more about the Future Perfect Tech podcast and webinar series at https://harborresearch.com/future-perfect-tech